ARGX Q2 2024 Earnings — argenx SE Revenue & Financial Results | Market Cap Arena

ARGXargenx SE

$46B

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$902M+92.6% YoY

Gross Profit

$1.3B142.1% margin

Operating Income

-$139M-15.4% margin

Net Income

-$33M-3.6% margin

EPS (Diluted)

$-0.55

QoQ Revenue Growth

+124.9%

Cash Flow

Operating Cash Flow

-$125M

Free Cash Flow

-$125M

Stock-Based Comp.

$103M

Balance Sheet

Total Assets

$4.8B

Total Liabilities

$534M

Stockholders' Equity

$4.3B

Cash & Equivalents

$1.4B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$902M	$468M	+92.6%
Gross Profit	$1.3B	$107M	+1095.6%
Operating Income	-$139M	-$189M	+26.4%
Net Income	-$33M	-$113M	+71.2%